176 related articles for article (PubMed ID: 6689389)
21. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
Kośmicki M; Sadowski Z
Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
[TBL] [Abstract][Full Text] [Related]
22. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
Fach WA; Becker HJ
Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog.
Martorana PA; Kettenbach B; Göbel H; Nitz RE
Basic Res Cardiol; 1984; 79(5):503-12. PubMed ID: 6439183
[TBL] [Abstract][Full Text] [Related]
24. [Synergic action of molsidomine and atenolol in patients with exertion angina. Cycloergometric study].
Gimeno JV; Olagüe J; Bueno FJ; Tellols R; Martín G; Ferrer J
Med Clin (Barc); 1984 Nov; 83(15):624-8. PubMed ID: 6549203
[No Abstract] [Full Text] [Related]
25. Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction.
Aptecar M; Otero y Garzon CA; Vasquez A; Varini S; Collia L; Esteguy A; Caruso S
Am Heart J; 1981 Apr; 101(4):369-73. PubMed ID: 6894215
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
[TBL] [Abstract][Full Text] [Related]
27. [Use of the vasodilator molsidomin in the treatment of chronic cardiac insufficiency].
Mareev VIu; Sazonova LN; Grigor'iants RA; Lobova NM; Irani RM
Ter Arkh; 1983; 55(9):76-80. PubMed ID: 6688891
[No Abstract] [Full Text] [Related]
28. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
Kośmicki M; Sadowski Z; Szwed H; Kowalik I
Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
[TBL] [Abstract][Full Text] [Related]
29. [Molsidomine in exertion angina].
Witchitz S; Kolsky H; Moisson P
Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):539-43. PubMed ID: 6689396
[TBL] [Abstract][Full Text] [Related]
30. [Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite].
Schulz W; Wendt T; Scherer D; Kober G
Z Kardiol; 1983 Jul; 72(7):404-9. PubMed ID: 6613236
[TBL] [Abstract][Full Text] [Related]
31. Tolerance development during isosorbide dinitrate treatment: can it be circumvented?
Rudolph W; Blasini R; Reiniger G; Brügmann U
Z Kardiol; 1983; 72 Suppl 3():195-8. PubMed ID: 6421009
[TBL] [Abstract][Full Text] [Related]
32. [Molsidomine and isosorbide dinitrate: a comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort].
Alimova EV; Martsevich SIu; Kutishenko NP; Metelitsa VI
Ter Arkh; 1997; 69(12):37-40. PubMed ID: 9503532
[TBL] [Abstract][Full Text] [Related]
33. Does chronic nitrate therapy induce tolerance to short-acting ones?
Bultas J; Karetová D
Sb Lek; 1993; 94(1):71-5. PubMed ID: 7992001
[TBL] [Abstract][Full Text] [Related]
34. [Comparative hemodynamic studies with molsidomine and isosorbide dinitrate after aortocoronary bypass].
Fritz KW; Eglins P; Höge B; Hehrlein FW; Lüllwitz E; Kirchner E
Intensivmed Prax; 1982 Jun; 5():27-38. PubMed ID: 6984020
[No Abstract] [Full Text] [Related]
35. Haemodynamic effects of molsidomine in patients with severe chronic coronary disease.
Crexells C; Lidón RM; Augé JM; Bosch X; Pina C; Garcia J; Oriol A
Eur Heart J; 1985 Dec; 6(12):1032-9. PubMed ID: 3841658
[TBL] [Abstract][Full Text] [Related]
36. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
37. [Comparative evaluation of antianginal efficacy of isosorbide dinitrate in various doses in patients with stable angina].
Kośmicki M; Sadowski Z
Wiad Lek; 2000; 53(7-8):388-93. PubMed ID: 11070759
[TBL] [Abstract][Full Text] [Related]
38. [The possibility of the development of isosorbide dinitrate and nifedipine withdrawal syndromes in patients with stable stenocardia of effort].
Kutishenko NP; Martsevich SIu; Metelitsa VI
Ter Arkh; 1997; 69(9):47-51. PubMed ID: 9411826
[TBL] [Abstract][Full Text] [Related]
39. [Longterm effect and maintenance therapy with cutaneous isosorbide dinitrate in patients with coronary heart disease (author's transl)].
Brunner D; Weisbord J; Meshulam N; Margulis S
MMW Munch Med Wochenschr; 1980 May; 122(21):801-6. PubMed ID: 6771600
[TBL] [Abstract][Full Text] [Related]
40. Pre- and afterload reduction in chronic mitral regurgitation: a double-blind randomized placebo-controlled trial of the acute and 2 weeks' effect of nifedipine or isosorbide dinitrate treatment on left ventricular function and the severity of mitral regurgitation.
Kelbaek H; Aldershvile J; Skagen K; Hildebrandt P; Nielsen SL
Br J Clin Pharmacol; 1996 Jun; 41(6):493-7. PubMed ID: 8799512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
